1600-6143/asset/olbannerleft.gif?v=1&s=c46a3f174bfd9c6eb548cc809401524372c32e90)
1600-6143/asset/olbannerright.gif?v=1&s=9fc9790fa8ad5ef85aeaf408bf0d3d969d2fc012)
You have full text access to this OnlineOpen article
Successful Long-Term Outcome of the First Combined Heart and Kidney Transplant in a Patient with Systemic AL Amyloidosis
Article first published online: 4 DEC 2008
DOI: 10.1111/j.1600-6143.2008.02469.x
© 2009 The Authors Journal compilation © 2009 The American Society of Transplantation and the American Society of Transplant Surgeons
1600-6143/asset/cover.gif?v=1&s=c55cd883bd7585782204dad5ade568d8249afb19 "American Journal of Transplantation")
Additional Information
How to Cite
Audard, V., Matignon, M., Weiss, L., Remy, P., Pardon, A., Haioun, C., Belhadj, K., Salomon, L., Hillon, M. L., Sahali, D., Vermes, E., Lang, P. and Grimbert, P. (2009), Successful Long-Term Outcome of the First Combined Heart and Kidney Transplant in a Patient with Systemic AL Amyloidosis. American Journal of Transplantation, 9: 236–240. doi: 10.1111/j.1600-6143.2008.02469.x
Publication History
- Issue published online: 19 DEC 2008
- Article first published online: 4 DEC 2008
- Received 20 August 2008, revised and accepted for publication 17 September 2008
References
- 1, . Molecular mechanisms of amyloidosis. N Engl J Med 2003; 349: 583–596.
- 2. Light-chain (AL) amyloidosis: diagnosis and treatment. Clin J Am Soc Nephrol 2006; 1: 1331–1341.
- 3, , . The systemic amyloidoses. N Engl J Med 1997; 337: 898–909.
- 4. Amyloidosis-associated kidney disease. J Am Soc Nephrol 2006; 17: 3458–3471.
- 5, . Autologous stem cell transplantation for primary systemic amyloidosis. Blood 2002; 99: 4276–4282.
- 6
- 7, , et al. Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease. Ann Intern Med 2001; 134: 746–753.
- 8, , et al. High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: An 8-year study. Ann Intern Med 2004; 140: 85–93.
- 9, , et al. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. N Engl J Med 2007; 357: 1083–1093.
- 10, , et al. High treatment-related mortality in cardiac amyloid patients undergoing autologous stem cell transplant. Bone Marrow Transplant 1999; 24: 853–855.
- 11, , et al. Stem cell transplantation for the management of primary systemic amyloidosis. Am J Med 2002; 113: 549–555.
- 12, , et al. Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis. Blood 2006; 107: 1227–1229.
- 13, , et al. Long-term successful outcome of sequential cardiac and allogeneic bone marrow transplantations in severe AL amyloidosis. Bone Marrow Transplant 2005; 35: 419–420.
- 14, , et al. Treatment options for severe cardiac amyloidosis: Heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis. Eur J Cardiothorac Surg 2008; 33: 257–262.
- 15, , et al. Cardiac transplantation using extended-donor criteria organs for systemic amyloidosis complicated by heart failure. Transplantation 2007; 83: 539–545.
- 16, , et al. Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement. Am J Transplant 2005; 5: 1660–1670.
- 17, , , , , . Quantitative analysis of serum free light chains. A new marker for the diagnostic evaluation of primary systemic amyloidosis. Am J Clin Pathol 2003; 119: 274–278.
- 18, , et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains. Clin Chem 2002; 48: 1437–1444.
- 19, , . Perspectives in treatment of AL amyloidosis. Br J Haematol 2008; 140: 365–377.
- 20, , , , , . Long term results of heart transplantation in patients with amyloid heart disease. Heart 2001; 85: 202–207.
- 21, , et al. Heart transplantation in patients with amyloidosis: Single-center experience. Transplant Proc 2004; 36: 643–644.
- 22, , , . Cardiac transplantation for amyloid heart disease: The United Kingdom experience. J Heart Lung Transplant 2004; 23: 1142–1153.
- 23, , , . Outcome of heart transplantation in patients with amyloid cardiomyopathy. J Heart Lung Transplant 2005; 24: 1763–1765.
- 24
- 25, , , , , . The role of renal transplantationin systemic AL amyloidosis. Blood 106, 3497 (Abstract).